Dr. Benjamin John Thomas, MD

Dr. Thomas practices at Retina Group of Florida in Brooksville, Florida.

Dr. Thomas' NPI, 1427290360, was assigned on March 24, 2009. Dr. Thomas graduated from Medical University of South Carolina (MUSC) in 2009. Dr. Thomas holds Florida license ME127512.

Dr. Thomas' primary practice is Retina Group of Florida, at 11373 Cortez Blvd, Brooksville, FL 34613 in Hernando County. The practice phone is (954) 776-6880.

Dr. Thomas' primary practice is Retina Group of Florida in Brooksville, Florida. Dmand AI also links Dr. Thomas to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thomas practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Thomas' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Thomas is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Thomas' licenses on file in 5 states: Florida, South Carolina, Georgia, Michigan and Utah.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, eyelid inflammation, glaucoma, hypertensive retinopathy, laser destruction of retinal or choroid lesions and retinal detachment among the conditions Dr. Thomas treats.

CMS data shows 27,410 Medicare services from Dr. Thomas across 25 procedure codes in 2024, for 985 Medicare patients. Medicare paid $2,796,143 for them.

CMS counts 985 Medicare patients who saw Dr. Thomas in 2024. The largest group is 65 to 74, with 390 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thomas' median patient age at 73, with 59% women.

In 2024, Dr. Thomas wrote 1,216 Medicare Part D claims for 293 patients. 61% of them were for generic drugs. CMS names the drug for 1,098 of them, across 16 drugs with 11 or more claims each, at $230,806 in total drug cost. In 2023, CMS named 1,147 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Thomas for performance year 2024, reported individually.

Dmand AI links 39 papers to Dr. Thomas, published from 2013 to 2020. 2016 was the busiest year, with 6. The most frequent topics are Vitrectomy, Visual Acuity and Tomography, Optical Coherence. Dr. Thomas has published most often in Retina. Dr. Thomas' most frequent co-authors are Antonio Capone, MD, Aristomenis Thanos, MD and Ashkan Michael Abbey, MD.

CMS Open Payments shows 280 general payments to Dr. Thomas from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Allergan Inc. paid the most, $32,522.

Dr. Thomas graduated from Medical University of South Carolina (MUSC) in 2009.

Dr. Thomas is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.